title: Identifying and addressing the toxicity of checkpoint inhibitors in lung cancer.
authors.affiliation: Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Medicine, Baltimore, Maryland.
authors.forename: Julie R
authors.initials: JR
authors.lastname: Brahmer
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001327:Autoimmune Diseases / Q000175:diagnosis / Q000209:etiology; D060890:B7-H1 Antigen / Q000037:antagonists & inhibitors; D060908:CTLA-4 Antigen / Q000037:antagonists & inhibitors; D006801:Humans; D007167:Immunotherapy / Q000009:adverse effects; D008175:Lung Neoplasms / Q000150:complications / Q000188:drug therapy* / Q000276:immunology / Q000378:metabolism; D058990:Molecular Targeted Therapy / Q000009:adverse effects*; D061026:Programmed Cell Death 1 Receptor / Q000037:antagonists & inhibitors
chemical_list: D000970:Antineoplastic Agents; D060890:B7-H1 Antigen; D060908:CTLA-4 Antigen; D061026:Programmed Cell Death 1 Receptor